Naoyuki Chosa

Naoyuki Chosa

Auto-generated profile, based on publicly available information

Naoyuki Chosa

Division of Cellular Biosignal Sciences, Department of Biochemistry, Iwate Medical University, Yahaba, Iwate, 028-3694, Japan

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in Developmental Cell
Verified
Journal Article
Closed access
IJIn-Hwan Jang
In-Hwan Jang
NCNaoyuki Chosa
Naoyuki Chosa
SKSung-Hee Kim
Sung-Hee Kim
HNHyuck-Jin Nam
Hyuck-Jin Nam
BLBruno Lemaitre
Bruno Lemaitre
WLWon-Jae Lee
Won-Jae Lee

13 January 2014 in Scientific Reports
Verified
Journal Article
Open access
PDF file
EAEmiko Aomatsu
Emiko Aomatsu
NTNoriko Takahashi
Noriko Takahashi
SSShunsuke Sawada
Shunsuke Sawada
NONaoto Okubo
Naoto Okubo
THTomokazu Hasegawa
Tomokazu Hasegawa
NCNaoyuki Chosa
Naoyuki Chosa
Human mesenchymal stem cells (hMSCs) remodel or regenerate various tissues through several mechanisms. Here, we identified the hMSC-secreted protein SCRG1 and its receptor BST1 as a positive regulator of self-renewal, migration, and osteogenic differentiation. SCRG1 and BST1 gene expression decreased during osteogenic differentiation of hMSCs. Intriguingly, SCRG1 maintained stem cell marker expression (Oct-4 and CD271/LNGFR) and the potentials of self-renewal, migration, and osteogenic differentiation, even at high passage numbers. Thus, the novel SCRG1/BST1 axis determines the fate of hMSCs by regulating their kinetic and differentiation potentials. Our findings provide a new perspective on methods for ex vivo expansion of hMSCs that maintain native stem cell potentials for bone-forming cell therapy.

1 January 2013 in Biomedical Research
Verified
Journal Article
Closed access
SSShunsuke Sawada
Shunsuke Sawada
NCNaoyuki Chosa
Naoyuki Chosa
AIAkira Ishisaki
Akira Ishisaki
KNKoji Naruishi
Koji Naruishi
Internleukin-1 (IL-1) and IL-6 are the most potent proinflammatory cytokines being involved in inflammatory diseases such as periodontitis. The objective of this study was to examine the synergistic effects of IL-1β and IL-6 on gingival inflammation by targeting cultured human gingival fibroblasts (HGFs). HGFs were treated with IL-1β or IL-6/soluble IL-6R (sIL-6R), and total RNA and total cell lysate were collected to examine expression of gp130 known as a signal transducer of IL-6 using qRT-PCR and Western blotting. IL-1β-mediated IL-6 productivity in HGFs was examined using ELISA method. Likewise, after HGFs and THP-1 macrophages were treated with IL-1β, TNF-α and IL-6, sIL-6R productivity was examined. Next, HGFs were treated with IL-6/ sIL-6R after pretreatment of IL-1β, and the intracellular signals were examined using Western blotting. Finally, various mRNA/protein expressions in HGFs treated with IL-6/sIL-6R after pretreatment of IL-1β were examined using qRT-PCR and ELISA method. IL-1β increased significantly both gp130 and IL-6 expression in HGFs. IL-6 increased significantly sIL-6R production in THP-1 macrophages but not HGFs. Co-stimulation with IL-1β and IL-6/sIL-6R induced dramatically the phosphorylation of Stat3, ERK and JNK in HGFs. Interestingly, expression of various inflammation- related molecules such as MMP-1, MCP-1, IL-1ra, bFGF and VEGF were enhanced by co-stimulation with IL-1β and IL-6/sIL-6R in HGFs. Gingival inflammation is regulated by HGFs affected by both IL-1β and IL-6/sIL-6R synergistically through induction of gp130 expression, resulting in progression of periodontitis.

1 January 1997 in Insect Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
NCNaoyuki Chosa
Naoyuki Chosa
TFTakashi Fukumitsu
Takashi Fukumitsu
KFKengo Fujimoto
Kengo Fujimoto
EOEiji Ohnishi
Eiji Ohnishi

1 September 2017 in Experimental Cell Research
Verified
Journal Article
Open access
NTNaoki Takizawa
Naoki Takizawa
NONaoto Okubo
Naoto Okubo
MKMasaharu Kamo
Masaharu Kamo
NCNaoyuki Chosa
Naoyuki Chosa
TMToshinari Mikami
Toshinari Mikami
SKSeiko Kyakumoto
Seiko Kyakumoto
Immunosuppressive/anti-inflammatory macrophage (Mφ), M2-Mφ that expressed the typical M2-Mφs marker, CD206, and anti-inflammatory cytokine, interleukin (IL)-10, is beneficial and expected tool for the cytotherapy against inflammatory diseases. Here, we demonstrated that bone marrow-derived lineage-positive (Lin+) blood cells proliferated and differentiated into M2-Mφs by cooperation with the bone marrow-derived mesenchymal stem cells (MSCs) under hypoxic condition: MSCs not only promoted proliferation of undifferentiated M2-Mφs, pre-M2-Mφs, in the Lin+ fraction via a proliferative effect of the MSCs-secreted macrophage colony-stimulating factor, but also promoted M2-Mφ polarization of the pre-M2-Mφs through cell-to-cell contact with the pre-M2-Mφs. Intriguingly, an inhibitor for intercellular adhesion molecule (ICAM)-1 receptor/lymphocyte function-associated antigen (LFA)-1, Rwj50271, partially suppressed expression of CD206 in the Lin+ blood cells but an inhibitor for VCAM-1 receptor/VLA-4, BIO5192, did not, suggesting that the cell-to-cell adhesion through LFA-1 on pre-M2-Mφs and ICAM-1 on MSCs was supposed to promoted the M2-Mφ polarization. Thus, the co-culture system consisting of bone marrow-derived Lin+ blood cells and MSCs under hypoxic condition was a beneficial supplier of a number of M2-Mφs, which could be clinically applicable to inflammatory diseases.

1 March 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
YKYosuke Kanno
Yosuke Kanno
AIAkira Ishisaki
Akira Ishisaki
EKEri Kawashita
Eri Kawashita
NCNaoyuki Chosa
Naoyuki Chosa
KNKeiichi Nakajima
Keiichi Nakajima
HMHiroyuki Matsuno
Hiroyuki Matsuno
The contribution of plasminogen (Plg)/plasmin, which have claimed to be the main fibrinolytic regulators in the bone metabolism, remains unclear. This study evaluated how the absence of Plg affects the function of osteoblast (OB) and osteoclast (OC). There was a larger population of pre-OCs in bone marrow-derived cells from the Plg−/− mice than the population of that from the WT mice. In addition, the absence of Plg suppressed the expression of osteoprotegerin in OBs. Moreover, an exogenous plasmin clearly induced the osteoprotegerin expression in Plg−/− OBs. The osteoclastogenesis of RAW264.7 mouse monocyte/macrophage lineage cells in co-culture with OBs from the Plg−/− mice was significantly accelerated in comparison with that in co-culture with OBs from the WT mice. Intriguingly, the accelerated OC differentiation of RAW264.7 cells co-cultured with Plg−/− OBs was clearly suppressed by the treatment of an exogenous plasmin. Consequently, Plg−/− mice display decreased bone mineral density. These findings could eventually lead to the development of new clinical therapies for bone disease caused by a disorder of the fibrinolytic system.